Estimation and inference on average treatment effect in percentage points under heterogeneity
异质性下百分点平均处理效应的估计与推断AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要直接研究平均处理效应、异质性及交错实施的双重差分设计。
异质性下百分点平均处理效应的估计与推断AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
In semi-logarithmic regressions, treatment coefficients are often interpreted as approximations of an average treatment effect (ATE) in percentage points. This paper highlights the overlooked bias of this approximation under treatment effect heterogeneity, arising from Jensen’s inequality. The issue is particularly relevant for difference-in-differences designs with log-transformed outcomes and staggered treatment adoption, where treatment effects may vary across groups and periods. This paper proposes new estimation and inference methods for an estimand that accounts for heterogeneity across observable subgroups and can improve upon conventional measures. The estimand provides a lower bound on the ATE in percentage points for the relevant target (sub)population, and coincides with it in the absence of within-group heterogeneity. I establish the methods’ large-sample properties and study their finite-sample performance through Monte Carlo experiments, which reveal substantial discrepancies between conventional and proposed measures when systematic heterogeneity is large. Two empirical applications further underscore the practical importance of these methods.